|
22/04/2013 |
Ad hoc: MorphoSys to Start Share Buy-Back Program |
 |
|
16/12/2012 |
Ad hoc: Bio-Rad to Acquire MorphoSys's Research and Diagnostic Antibody Business AbD Serotec |
|
|
20/09/2012 |
Ad hoc: MorphoSys's MOR103 Antibody Demonstrates Excellent Safety and Efficacy in Rheumatoid Arthritis Patients |
|
|
01/04/2012 |
Ad hoc: MorphoSys to Start Share Buy-Back Program |
|
|
01/06/2011 |
Ad hoc: MorphoSys to Start Share Buy-Back Program |
|
|
21/01/2011 |
Ad hoc: MorphoSys Reports Preliminary, Unaudited Financial Results |
|
|
10/12/2010 |
Ad hoc: MorphoSys Increases Revenues and Operating Profit Guidance for 2010 |
|
|
07/10/2010 |
Ad hoc correction: MorphoSys Announces Acquisition of Sloning |
|
|
07/10/2010 |
Ad hoc: MorphoSys Announces Acquisition of Sloning |
|
|
27/06/2010 |
Ad hoc: MorphoSys and Xencor Sign License and Collaboration Agreement for Clinical Antibody Program |
|
|
02/12/2007 |
Ad hoc: 1-MorphoSys and Novartis Forge New Strategic Alliance to Establish Innovative Therapeutic Antibody Pipeline |
|
|
02/12/2007 |
Ad hoc: 2-MorphoSys Financial Guidance 2007 Under Review |
|
